Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B

Biochemical and Biophysical Research Communications

Volumn 334, Issue 1, 2005, Pages 207-212

  Tarnawski, A ^a,b   Pai, R ^b   Chiou, S K ^a,b   Chai, J ^a,b   Chu, E C ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Aurora B; Gastric cancer; Proteasome inhibitor; Rebamipide; Survivin

Indexed keywords

AURORA B KINASE; PHOSPHOTRANSFERASE; PROTEASOME; REBAMIPIDE; SMALL INTERFERING RNA; SURVIVIN; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GASTRITIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CANCER;

ALANINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; QUINOLONES; STOMACH NEOPLASMS;

EID: 22144464871     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.05.204     Document Type: Article

References (29)

1. T. Arakawa, T. Watanabe, T. Fukuda, K. Yamasaki, and K. Kobayashi Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer, comparison with cimetidine Dig. Dis. Sci. 40 1995 2469 2472
2. T. Arakawa, K. Kobayashi, T. Yoshikawa, and A. Tarnawski Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing Dig. Dis. Sci. 43 9 Suppl. 1 1998 5S 13S
3. A.S. Tarnawski, J. Chai, R. Pai, and S.-K. Chiou Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action Dig. Dis. Sci. 49 2004 202 209
4. G. Ambrosini, C. Adida, and D.C. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat. Med. 3 1997 917 921
5. D.C. Altieri, P.C. Marchisio, and C. Marchisio Survivin apoptosis: an interloper between cell death and cell proliferation in cancer Lab. Invest. 79 1999 1327 1333
6. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
7. F. Li, E.J. Ackermann, C.F. Bennett, A.L. Rothermel, J. Plescia, S. Tognin, A. Villa, P.C. Marchisio, and D.C. Altieri Pleiotropic cell-division defects and apoptosis induced by interference with survivin function Nat. Cell Biol. 1 1999 461 466
8. A. Giodini, M.J. Kallio, N.R. Wall, G.J. Gorbsky, S. Tognin, P.C. Marchisio, M. Symons, and D.C. Altieri Regulation of microtubule stability and mitotic progression by survivin Cancer Res. 62 2002 2462 2467
9. D.C. Altieri Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm J. Cell. Biochem. 92 2004 656 663
10. C.D. Lu, D.C. Altieri, and N. Tanigawa Expression of a novel antiapoptosis gene, survivin, correlated with tumor apoptosis and p53 accumulation in gastric carcinomas Cancer Res. 58 1998 1808 1812
11. Y. Wakana, K. Kasuya, S. Katayanagi, A. Tsuchida, T. Aoki, Y. Koyanagi, H. Ishii, and Y. Ebihara Effect of survivin on cell proliferation and apoptosis in gastric cancer Oncol. Rep. 9 2002 1213 1218
12. J. Kania, S.J. Konturek, K. Marliez, E.G. Hahn, and P.C. Konturek Expression of survivin and caspase-3 in gastric cancer Dig. Dis. Sci. 48 2003 266 271
13. M. Ikeguchi, and N. Kaibara Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer Int. J. Mol. Med. 8 2001 661 666
14. M. Ikeguchi, J. Liu, and N. Kaibara Expression of survivin mRNA and protein in gastric cancer cell line (MKN) during cisplatin treatment Apoptosis 7 2002 23 29
15. S.-K. Chiou, W.S. Moon, M.K. Jones, and A.S. Tarnawski Survivin expression in stomach: implications for mucosal integrity and protection Biochem. Biophys. Res. Commun. 305 2003 374 379
16. S.-K. Chiou, T. Tanigawa, T. Akahoshi, B. Abdelkarim, M.K. Jones, and A.S. Tarnawski Survivin: a novel target for indomethacin-induced gastric injury Gastroenterology 128 2005 63 73
17. M.J. Kallio, M.L. McCleland, P.T. Stukenberg, and G.J. Gorbsky Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis Curr. Biol. 12 2002 900 905
18. C. Ditchfield, V.L. Johnson, A. Tighe, R. Ellston, C. Haworth, T. Johnson, A. Mortlock, N. Keen, and S.S. Taylor Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores Cell Biol. 161 2003 267 280
19. R. Honda, R. Korner, and E.A. Nigg Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis Mol. Biol. Cell 14 2003 3325 3341
20. W. Lan, X. Zhang, S.L. Kline-Smith, S.E. Rosasco, G.A. Barrett-Wilt, J. Shabanowitz, D.F. Hunt, C.E. Walczak, and P.T. Stukenberg Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity Curr. Biol. 14 2004 273 286
21. T. Marumoto, D. Zhang, and H. Saya Aurora-A-a guardian of poles Nat. Rev. Cancer 5 2005 42 50
22. H. Katayama, W.R. Brinkley, and S. Sen The Aurora kinases: role in cell transformation and tumorigenesis Cancer Metastasis Rev. 4 2003 451 464
23. R. Sorrentino, S. Libertini, P.L. Pallante, G. Troncone, L. Palombini, V. Bavetsias, D. Spalletti-Cernia, P. Laccetti, S. Linardopoulos, P. Chieffi, A. Fusco, and G. Portella Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation J. Clin. Endocrinol. Metab. 90 2005 928 935
24. J. Zhao, T. Tenev, L.M. Martins, J. Downward, and N.R. Lemoine The ubiquitin-proteasome pathway regulates survivin degradation in cell cycle-dependent manner J. Cell Sci. 113 2000 4363 4371
25. A. Tarnawski, T. Brzozowski, I.J. Sarfeh, W.J. Krause, T.R. Ulich, H. Gergely, and D. Hollander Prostaglandin protection of human isolated gastric glands against indomethacin and alcohol injury. Evidence for direct cellular action of prostaglandin J. Clin. Invest. 81 1988 1081 1089
26. J. Chai, M.K. Jones, and A.S. Tarnawski Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis FASEB J. 18 2004 1264 1266
27. M. Cervello, L. Giannitrapani, M. La Rosa, M. Labbozzetta, P. Poma, G. Montalto, and N. D'Alessandro Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation Int. J. Mol. Med. 13 2004 741 748
28. Y. Naito, T. Yoshikawa, S. Iinuma, R. Miyazaki, N. Yagi, N. Yoshida, T. Osumi, Y. Hirao, and M. Kondo Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis Arzneimittelforschung 46 1996 698 700
29. T. Yamane, N. Nakatani, H. Masumoto, Y. Iwata, N. Kikuoka, and T. Takahashi Inhibitory effects of rebamipide on ENNG-induced duodenal carcinogenesis in mice: a possible strategy for chemoprevention of gastrointestinal cancers Dig. Dis. Sci. 43 1998 207S 211S